GlassScriptPhysician profile
Sara Khoshbin
NPI 1811263734
$1,004.52
in general payments reported to CMS, 2019-2025
7 companies · $787 in 2025
The $787 reported for 2025 was more than what 95% of Pediatric Dentistry providers received nationally (typical 2025 total: $42.86).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2021: $11.45 · 2023: $69.59 · 2025: $787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $750 · Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $750.00 |
| Food and Beverage | $106.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $750.00 | 2025 | |
| Zimmer Biomet Holdings, INC. | $124.91 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $69.59 | 2023 | Arestin |
| American Orthodontics Corporation | $23.13 | 2025 | Empower-Metal, LP and Ifit Tubes, Radiance |
| Elevate Oral Care | $13.50 | 2025 | Just Right 5000, Fluorimax Mint, Fluorimax 5000 |
| Biolase, INC. | $11.94 | 2019 | |
| Dentsply Sirona INC | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Khoshbin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.